Hemofarm Executive and Leadership Team

Ronald Seeliger, the Chief Executive Officer at Hemofarm, directs the overarching corporate strategy and manufacturing excellence for the organization. Overseeing the production of over 4 billion tablets and capsules annually, the Chief Executive Officer ensures operational efficiency across all pharmaceutical facilities. This leadership role involves maintaining the 17.3% market share within the Serbian pharmaceutical sector while driving expansion initiatives throughout the broader region. By aligning production capacity with international quality standards, Ronald Seeliger optimizes the supply chain to meet rising demand for medicinal products. The Chief Executive Officer coordinates with the board to prioritize long-term growth and sustainable health outcomes. Through rigorous oversight of manufacturing processes, Seeliger secures the company's status as a premier pharmaceutical manufacturer. This executive leadership fosters innovation in drug development, ensuring that the company remains at the forefront of the industry while delivering consistent value to stakeholders and patients alike.

Dr. Seeliger, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm at Hemofarm, manages the strategic integration of the Balkan cluster operations. Overseeing the export strategy, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm drives the 79.1% share of Serbian pharmaceutical exports to international markets. This role requires constant collaboration with regional stakeholders to expand the footprint of medicinal products beyond domestic borders. By leveraging the manufacturing scale of the company, Dr. Seeliger ensures that regional distribution networks remain robust and responsive to market fluctuations. The President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm focuses on harmonizing regulatory compliance across multiple jurisdictions to facilitate seamless trade. Through this expansive operational scope, Seeliger strengthens the competitive advantage of the organization in the global pharmaceutical landscape. This leadership position remains vital for sustaining the company's reputation as the leading exporter of medicinal products in the region.

Vidosava Aleksic, the Chief Financial Officer, Pomocnik at Hemofarm, manages the fiscal health and capital allocation strategies for the entire pharmaceutical enterprise. Overseeing financial reporting and budgetary planning, the Chief Financial Officer, Pomocnik ensures that the company maintains its 17.3% financial market share through disciplined investment in manufacturing technology. This role involves analyzing revenue streams from the massive annual production of tablets and capsules to optimize profitability. By directing financial risk management, Vidosava Aleksic supports the long-term stability of the organization during periods of regional expansion. The Chief Financial Officer, Pomocnik collaborates with executive leadership to allocate resources toward research and development, ensuring that financial targets align with the core mission of health care. Through precise fiscal oversight, Aleksic provides the necessary capital structure to sustain the company's dominant position in the Serbian market. This leadership function remains essential for maintaining investor confidence and operational liquidity.

Tijana Marković, the Chief Marketing Officer, Fmd & Specialist at Hemofarm, architects the brand strategy and market positioning for the company's extensive portfolio of medicinal products. Overseeing the promotion of pharmaceutical solutions, the Chief Marketing Officer, Fmd & Specialist drives engagement with healthcare providers and patients to maintain the company's leading market share. This role involves analyzing market trends to identify growth opportunities for specialized drug categories. By coordinating with sales teams, Tijana Marković ensures that the value proposition of the company's products reaches key regional demographics effectively. The Chief Marketing Officer, Fmd & Specialist develops campaigns that emphasize the commitment to health and quality, reinforcing the brand's reputation as a trusted pharmaceutical leader. Through strategic market analysis, Marković identifies emerging needs within the industry, allowing the company to adapt its product offerings accordingly. This leadership role directly impacts the visibility and commercial success of the organization across the Balkan region.